ARTICLE | Company News
Abbott gets accelerated approval for Kaletra
September 18, 2000 7:00 AM UTC
ABT received accelerated marketing approval from the FDA for its Kaletra lopinavir/ritonavir to treat HIV infection in adults and children over six months, in combination with other antiretrovirals. T...